Document
Academic Article
Generically Dependent Continuant
Daratumumab Plus CyBorD for Patients With Newly Diagnosed AL Amyloidosis: Safety Run-in Results of ANDROMEDA
Article
RDF description of Daratumumab Plus CyBorD for Patients With Newly Diagnosed AL Amyloidosis: Safety Run-in Results of ANDROMEDA - http://irises.unipv.it/resource/item/376663
Information Content Entity